DK455288D0 - Acylderivater - Google Patents

Acylderivater

Info

Publication number
DK455288D0
DK455288D0 DK455288A DK455288A DK455288D0 DK 455288 D0 DK455288 D0 DK 455288D0 DK 455288 A DK455288 A DK 455288A DK 455288 A DK455288 A DK 455288A DK 455288 D0 DK455288 D0 DK 455288D0
Authority
DK
Denmark
Prior art keywords
acyl derivatives
acyl
derivatives
Prior art date
Application number
DK455288A
Other languages
English (en)
Other versions
DK455288A (da
Inventor
Erwin Goetschi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK455288D0 publication Critical patent/DK455288D0/da
Publication of DK455288A publication Critical patent/DK455288A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK455288A 1987-08-14 1988-08-12 Acylderivater DK455288A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH313387 1987-08-14
CH472687 1987-12-03

Publications (2)

Publication Number Publication Date
DK455288D0 true DK455288D0 (da) 1988-08-12
DK455288A DK455288A (da) 1989-02-15

Family

ID=25692275

Family Applications (1)

Application Number Title Priority Date Filing Date
DK455288A DK455288A (da) 1987-08-14 1988-08-12 Acylderivater

Country Status (15)

Country Link
US (2) US5036064A (da)
EP (1) EP0303172A3 (da)
JP (1) JPS6466190A (da)
KR (1) KR890003776A (da)
AU (1) AU614984B2 (da)
DK (1) DK455288A (da)
FI (1) FI883766A7 (da)
HU (1) HUT47944A (da)
IL (1) IL87374A0 (da)
MC (1) MC1970A1 (da)
NO (1) NO883590L (da)
NZ (1) NZ225754A (da)
PH (1) PH25646A (da)
PT (1) PT88274B (da)
YU (1) YU156388A (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
US5030724A (en) * 1990-01-22 1991-07-09 E. R. Squibb & Sons, Inc. Monobactam hydrazides containing catechol sulfonic acid groups
US20040197408A1 (en) * 2002-12-30 2004-10-07 Angiotech International Ag Amino acids in micelle preparation
US7537532B2 (en) * 2007-05-16 2009-05-26 Young Carl D Handle for implement and method
KR101719556B1 (ko) * 2011-03-30 2017-03-24 주식회사 레고켐 바이오사이언스 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
WO2013051597A1 (ja) * 2011-10-04 2013-04-11 塩野義製薬株式会社 カテコール基を有するセフェム誘導体
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US10011715B2 (en) 2012-11-19 2018-07-03 Mitsui Chemicals, Inc. Polyester resin composition, manufacturing method therefor, and camera module containing said polyester resin composition
CN110279698B (zh) 2013-03-15 2022-10-28 默沙东有限责任公司 头孢特咯瓒抗生素组合物
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
GB1596278A (en) * 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4808711A (en) * 1985-01-21 1989-02-28 Sankei Pharmaceutical Co., Ltd. Cephalosporin derivatives
FI872879A7 (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
DE3840011A1 (de) * 1988-11-26 1990-05-31 Merck Patent Gmbh Benzoxazinderivate

Also Published As

Publication number Publication date
KR890003776A (ko) 1989-04-18
US5319140A (en) 1994-06-07
AU614984B2 (en) 1991-09-19
MC1970A1 (fr) 1989-09-29
NO883590D0 (no) 1988-08-12
NZ225754A (en) 1991-04-26
PH25646A (en) 1991-08-21
JPS6466190A (en) 1989-03-13
YU156388A (en) 1990-02-28
IL87374A0 (en) 1989-01-31
NO883590L (no) 1989-02-15
FI883766A7 (fi) 1989-02-15
AU2055488A (en) 1989-04-20
PT88274B (pt) 1995-03-01
US5036064A (en) 1991-07-30
PT88274A (pt) 1989-06-30
EP0303172A3 (de) 1991-05-15
HUT47944A (en) 1989-04-28
DK455288A (da) 1989-02-15
FI883766A0 (fi) 1988-08-12
EP0303172A2 (de) 1989-02-15

Similar Documents

Publication Publication Date Title
DK179388D0 (da) Acylderivater
TR26815A (tr) Azolilmetil-sikropil türevleri
DK263587A (da) Imidazoquinolinyletherderivater
ATA312487A (de) Tetrahydrocarbazolonderivate
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188A (da) Cholecalciferolderivater
DK455288A (da) Acylderivater
DK378088D0 (da) Alkenderivater
DK49688A (da) Propiolophenonderivater
DK170088D0 (da) Acylderivater
DK722988A (da) Acylderivater
DK271088A (da) Tienopyridinderivater
DK444687D0 (da) Alfa-substituerede ketonitron-derivater
FI893041A7 (fi) Substituoidut atsasykloheksyylijohdannaiset
DK676188D0 (da) Propanamidderivater
DK695788D0 (da) Naphtalenderivater
DK440687A (da) Bicyclooctanderivater
DK229887D0 (da) Alkenamidderivater
DK619187A (da) Isoindolderivater
DK323788D0 (da) Acylderivater
FI885063A7 (fi) Uudet 4-demetoksi-antrasykliinijohdannaiset
DK435087A (da) Isoprenderivater
DK71488D0 (da) Dipenylethylen-derivater
DK733688D0 (da) Dioxazocinderivater
DK440787A (da) Bicyclooctanderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment